Screener
ADC Therapeutics ADCT Q1 2025 earnings
Reported May 14, 2025 · Before market open
Revenue$23.0MBeat by $5.5M
EPS-$0.36Beat by $0.02
Revenue estimate$17.5M
EPS estimate-$0.38
Next report
Nov 10, 2026 (in 2 months)Revenue estimate$18.4M
EPS estimate-$0.21
Versus estimates
Revenue
Diluted EPS
FAQ
- When did ADC Therapeutics report Q1 2025 earnings?
- ADC Therapeutics (ADCT) reported Q1 2025 earnings on May 14, 2025 before market open.
- What were ADC Therapeutics's Q1 2025 revenue and EPS?
- ADC Therapeutics reported revenue of $23.0M and eps of $-0.36 for Q1 2025.
- Did ADC Therapeutics beat estimates in Q1 2025?
- Revenue beat the consensus estimate of $17.5M by $5.5M. EPS beat the consensus estimate of $-0.38 by $0.02.
- How did ADC Therapeutics's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 27.6% from $18.1M a year earlier and eps grew 35.7% from $-0.56.
- Where can I find ADC Therapeutics's Q1 2025 SEC filings?
- You can read the 8-K earnings release (0001628280-25-025329) and the 10-Q periodic report (0001628280-25-025481) directly on SEC EDGAR. The filing index links above go to sec.gov.
